SP

DRUG5 trials

Sponsors

London School of Hygiene and Tropical Medicine, Yonsei University, Epidemiological and Clinical Research Information Network, Ruijin Hospital

Conditions

Gastric AdenocarcinomaGastric CancerMalariaRecurrent or Metastatic Gastric CancerUrological Surgeries

Phase 2

Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

CompletedNCT01283204

Yonsei UniversityRecurrent or Metastatic Gastric Cancer

Start: 2010-03-09End: 2016-07-25Updated: 2019-01-29

XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer

Epidemiological and Clinical Research Information NetworkGastric Cancer

Start: 2011-08-31End: 2017-12-31Target: 100Updated: 2017-07-27

Phase 3

A Trial of Antimalarial Drugs Used in Pregnancy in Tanzania

CompletedNCT00146731

London School of Hygiene and Tropical MedicineMalaria

Start: 2004-01-31End: 2007-09-30Updated: 2017-01-12

Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer

Yonsei UniversityGastric Adenocarcinoma

Start: 2010-03-31End: 2016-03-31Target: 166Updated: 2013-06-04

Unknown Phase

A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological Surgeries

Ruijin HospitalUrological Surgeries

Start: 2023-02-22End: 2024-12-31Target: 15Updated: 2023-12-26

Related Papers

An update on the randomized phase III POST trial: S-1 based doublet as an adjuvant chemotherapy for curatively resected stage III gastric cancer.

Journal of Clinical Oncology2016-05-202 citations

Randomized phase II trial comparing 4 doublets as a front-line treatment in Asian patients with recurrent/metastatic gastric cancer.

Journal of Clinical Oncology2016-05-20

Randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) in gastric cancer patients with stage III (POST trial).

Journal of Clinical Oncology2014-05-20

A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II).

2012-07-2310 citations

Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.

2009-04-0845 citations